| Charing Cross Hospital |
The department was established in the early
nineteen sixties by Professor K.D. Bagshawe to develop effective
treatment of choriocarcinoma based on hCG measurement. Since
that time we have gained an international reputation in the
field of cancer diagnosis and treatment, acting as a referral
centre for the treatment of Germ-Cell tumours using hCG and
aFP. We are the largest of three UK centres funded by the Department
of Health for the management of Hydatidiform Mole. Uniquely,
we are an oncology laboratory located within a clinical oncology
department, with full access to the required expertise.
We aim to provide the clinician with the complete picture of
marker levels and our comprehensive reporting system produces
real-time graphs with up to four markers at one time. Together
with an analysis of the rates of change in a marker level, information
can be obtained about success of treatment or rapidity of tumour
growth. |
Director:
Professor M Seckl |
Deputy Director:
Dr Richard A Harvey |
Medical Oncology Dept.,
Charing Cross Hospital,
Fulham Palace Road,
LONDON,
W6 8RF
|
Tel:+44 (0)20 3311 1400
Fax:+44 (0)20 3311 1443
|
